GeneDx Income Before Tax from 2010 to 2025

WGSWW Stock   0.21  0.02  10.53%   
GeneDx Holdings Income Before Tax yearly trend continues to be fairly stable with very little volatility. Income Before Tax will likely drop to about -167 M in 2025. During the period from 2010 to 2025, GeneDx Holdings Income Before Tax regression line of quarterly data had mean square error of 15880.6 T and geometric mean of  64,460,441. View All Fundamentals
 
Income Before Tax  
First Reported
2010-12-31
Previous Quarter
-159 M
Current Value
-167 M
Quarterly Volatility
152.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Net Interest Income of 1.3 M, Interest Income of 3.1 M or Depreciation And Amortization of 31.3 M, as well as many indicators such as Price To Sales Ratio of 0.36, Dividend Yield of 0.0 or PTB Ratio of 0.52. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Income Before Tax Growth Pattern

Below is the plot of the Income Before Tax of GeneDx Holdings Corp over the last few years. Income Before Tax which can also be referred as pre-tax income is reported on GeneDx Holdings income statement and is an important metric when analyzing GeneDx Holdings Corp profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability. It is GeneDx Holdings' Income Before Tax historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
Income Before Tax10 Years Trend
Slightly volatile
   Income Before Tax   
       Timeline  

GeneDx Income Before Tax Regression Statistics

Arithmetic Mean(117,780,849)
Geometric Mean64,460,441
Coefficient Of Variation(129.20)
Mean Deviation110,096,061
Median(29,704,000)
Standard Deviation152,175,142
Sample Variance23157.3T
Range568.3M
R-Value(0.60)
Mean Square Error15880.6T
R-Squared0.36
Significance0.01
Slope(19,176,518)
Total Sum of Squares347359.1T

GeneDx Income Before Tax History

2025-167 M
2024-159 M
2023-176.7 M
2022-598 M
2021-245.4 M
2020-241.3 M

About GeneDx Holdings Financial Statements

GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Income Before Tax, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Before Tax-159 M-167 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.